Merck is a global pharmaceutical and chemical company with total revenues of EUR 7.6 billion in 2008, a history that began in 1668, and a future shaped by 32,800 employees in 59 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Merck KGaA deployed TEMIS to support hypothesis generation and validation services of their Research Knowledge Management department. Luxid® for Scientific Discovery detects the specific concepts of the Life Sciences domain such as biological and chemical entities or diseases as well as their respective relations to one another. Luxid® for Scientific Discovery give access to results through an intuitive interface in order to allow for the efficient detection of relevant pieces of information, and also for in-depth data mining.
by Luca Toldo and alexander Scheer (Department of Knowledge Management, Merck KGaA) http://trec.nist.gov/pubs/trec20/papers/merckkgaa.medical.update.pdf